Aurobindo Pharma falls on US FDA OAI at Lannett
Aurobindo Pharma fell 1.26% by 2 pm on 12 Nov 2026 after the US FDA classified its Lannett facility as OAI. Support is at 1,730 and resistance at 1,860. Aurobindo Pharma Limited [AUROPHARMA] extended losses for a second straight session o…






















